Literature DB >> 3546166

Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation.

R R Satoskar, S J Shah, S G Shenoy.   

Abstract

A new model for evaluating nonsteroidal anti-inflammatory drugs (NSAIDs) is described. In this model of postoperative inflammation, the anti-inflammatory activity of curcumin (diferuloyl methane) was investigated in comparison with phenylbutazone and placebo. Phenylbutazone and curcumin produced a better anti-inflammatory response than placebo.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3546166

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN： 0174-4879


  68 in total

1.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

2.  PARP inhibitor Olaparib Enhances the Apoptotic Potentiality of Curcumin by Increasing the DNA Damage in Oral Cancer Cells through Inhibition of BER Cascade.

Authors:  Sefinew Molla; Krushna Chandra Hembram; Subhajit Chatterjee; Deepika Nayak; Chinmayee Sethy; Rajalaxmi Pradhan; Chanakya Nath Kundu
Journal:  Pathol Oncol Res       Date:  2019-11-25       Impact factor: 3.201

3.  Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.

Authors:  Shijun Zhu; Terry W Moore; Xiaoqian Lin; Nao Morii; Alessandra Mancini; Randy B Howard; Deborah Culver; Richard F Arrendale; Prabhakar Reddy; Taylor J Evers; Hongzheng Zhang; Gabriel Sica; Zhuo G Chen; Aiming Sun; Haian Fu; Fadlo R Khuri; Dong M Shin; James P Snyder; Mamoru Shoji
Journal:  Integr Biol (Camb)       Date:  2012-04-25       Impact factor: 2.192

4.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

Review 5.  Photosensitizers in antibacterial photodynamic therapy: an overview.

Authors:  Jaber Ghorbani; Dariush Rahban; Shahin Aghamiri; Alireza Teymouri; Abbas Bahador
Journal:  Laser Ther       Date:  2018-12-31

Review 6.  Therapeutic roles of curcumin: lessons learned from clinical trials.

Authors:  Subash C Gupta; Sridevi Patchva; Bharat B Aggarwal
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

7.  Oxidative metabolites of curcumin poison human type II topoisomerases.

Authors:  Adam C Ketron; Odaine N Gordon; Claus Schneider; Neil Osheroff
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

Review 8.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

9.  Curcumin inhibits angiogenesis by up-regulation of microRNA-1275 and microRNA-1246: a promising therapy for treatment of corneal neovascularization.

Authors:  Yanhui Bai; Weiqun Wang; Guangli Sun; Mingchang Zhang; Jingmin Dong
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

10.  Curcumin decreases the expression of Pokemon by suppressing the binding activity of the Sp1 protein in human lung cancer cells.

Authors:  Jiajun Cui; Xianfeng Meng; Xudong Gao; Guangxuan Tan
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.